Testing effectiveness (Phase 2)Study completedNCT00044018What this trial is testingCDC-501 Therapy in Relapsed or Refractory Multiple MyelomaWho this might be right forMultiple Myeloma Celgene 102
Early research (Phase 1)UnknownNCT04295018What this trial is testingBCMA-directed CAR-T Cells Treatment in Subjects With r/r Multiple MyelomaWho this might be right forMultiple Myeloma Peking Union Medical College Hospital 10
Testing effectiveness (Phase 2)Study completedNCT02509546What this trial is testing8-Chloroadenosine in Treating Patients With Relapsed or Refractory Acute Myeloid LeukemiaWho this might be right forAcute Myeloid Leukemia Arising From Previous Myelodysplastic SyndromeRecurrent Acute Myeloid LeukemiaRefractory Acute Myeloid Leukemia City of Hope Medical Center 20
Early research (Phase 1)Looking for participantsNCT05963217What this trial is testingStudy of TBI-2001(Autologous CD19 Specific Chimeric Antigen Receptor (CAR) Gene-transduced T Lymphocytes) for Relapsed or Refractory CD19+ B-cell Lymphoma, CLL/SLLWho this might be right forRelapsed or Refractory CD19+ B-cell LymphomaRelapsed or Refractory Chronic Lymphocytic LeukemiaRelapsed or Refractory Small Lymphocytic Lymphoma University Health Network, Toronto 19
Testing effectiveness (Phase 2)Study completedNCT00002474What this trial is testingCombination Chemotherapy and Bone Marrow Transplant in Treating Patients With Refractory or Recurrent Ovarian CancerWho this might be right forOvarian Cancer Loyola University
Not applicableUnknownNCT01440413What this trial is testingStudy of the Response to a Neoadjuvant Chemotherapy Based on the Antitumor Immune Response in Localized Breast CancerWho this might be right forBreast Cancer Centre Leon Berard 40
Early research (Phase 1)Ended earlyNCT03547115What this trial is testingVoruciclib Alone or in Combination With Venetoclax in Subjects With B-Cell Malignancies or AMLWho this might be right forFollicular Lymphoma (FL)Mantle Cell Lymphoma (MCL)Marginal Zone Lymphoma (MZL)+4 more MEI Pharma, Inc. 84
Testing effectiveness (Phase 2)Ended earlyNCT00544674What this trial is testingPR104 in Treating Patients With Previously Untreated or Relapsed Small Cell Lung CancerWho this might be right forLung Cancer Proacta, Incorporated 5
Testing effectiveness (Phase 2)Ended earlyNCT04352413What this trial is testingPLM60 in Subjects With Relapsed Small-cell Lung Cancer After Platinum-based First-Line ChemotherapyWho this might be right forSmall Cell Lung Cancer CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 45
Testing effectiveness (Phase 2)UnknownNCT02134262What this trial is testingGene Therapy for B-Cell Non-Hodgkin Lymphoma Using CD19 CAR Gene Transduced T LymphocytesWho this might be right forRelapsed or Refractory B-Cell Non-Hodgkin Lymphoma Jichi Medical University 18
Early research (Phase 1)Looking for participantsNCT07025564What this trial is testingMiRisten for the Treatment of Relapsed or Refractory Acute Myeloid LeukemiaWho this might be right forRecurrent Acute Myeloid LeukemiaRefractory Acute Myeloid Leukemia City of Hope Medical Center 20
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06757387What this trial is testingChidamide Plus Golidocitinib in Relapsed/Refractory Peripheral T-Cell LymphomaWho this might be right forPeripheral T-cell Lymphoma Peking University Cancer Hospital & Institute 45
Large-scale testing (Phase 3)Looking for participantsNCT04794777What this trial is testingComparing "Salvage" Radiotherapy and Individualized PSMA PET/CT Targeted Treatment in With Relapsing Prostate CancerWho this might be right forProstate Cancer Stefan Carlsson 450
Testing effectiveness (Phase 2)Active Not RecruitingNCT02650401What this trial is testingStudy Of Entrectinib (Rxdx-101) in Children and Adolescents With Locally Advanced Or Metastatic Solid Or Primary CNS Tumors And/Or Who Have No Satisfactory Treatment OptionsWho this might be right forSolid TumorsCNS Tumors Hoffmann-La Roche 69
Early research (Phase 1)Study completedNCT01949519What this trial is testingDocetaxel and Lycopene in Metastatic Prostate CancerWho this might be right forAdenocarcinoma of the Prostate Medical University of South Carolina 24
Testing effectiveness (Phase 2)Study completedNCT03548207What this trial is testingJNJ-68284528, a Chimeric Antigen Receptor T Cell (CAR-T) Therapy Directed Against B-Cell Maturation Antigen (BCMA) in Participants With Relapsed or Refractory Multiple MyelomaWho this might be right forMultiple Myeloma Janssen Research & Development, LLC 126
Testing effectiveness (Phase 2)Active Not RecruitingNCT04086264What this trial is testingIMGN632 as Monotherapy or With Venetoclax and/or Azacitidine for Participants With CD123-Positive Acute Myeloid LeukemiaWho this might be right forAcute Myeloid Leukemia AbbVie 218
Testing effectiveness (Phase 2)Study completedNCT00831597What this trial is testingBendamustine Combined With Rituximab for Patients With Relapsed or Refractory Diffuse Large B-Cell LymphomaWho this might be right forDiffuse Large B-Cell Lymphoma Pharmatech 61
Early research (Phase 1)UnknownNCT05989724What this trial is testingA First-in-Human Study of SON-DP in Participants With Relapsed/Refractory Intolerant to Standard of Care Therapies for Advanced/Metastatic Solid TumorsWho this might be right forSolid TumorBreast CancerPancreatic Cancer+2 more Qurgen Inc. 150
Testing effectiveness (Phase 2)Ended earlyNCT01646762What this trial is testingPaclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Relapsed or Refractory Multiple MyelomaWho this might be right forRefractory Plasma Cell Myeloma Mayo Clinic 13